Cognitive Dysfunction: Clinical Manifestations

The neurological abnormalities described above manifest clinically as characteristic patterns of cognitive dysfunction, often described by patients as “brain fog.”

1 Domains of Impairment

1.1 Processing Speed

Slowed information processing is perhaps the most consistent cognitive finding, manifesting as delayed reaction times, slower performance on timed tasks, reduced ability to keep up with rapid conversations, and difficulty with time-pressured activities.

The meta-analysis by Aoun Sebaiti et al. identifies processing speed as the most impaired domain in ME/CFS, with a large effect size of \(g = -0.82\) (reading speed) (Aoun Sebaiti et al. 2022). The multi-site MCAM study confirms this using objective CogState testing across seven US clinics (\(n = 426\)): processing speed was significantly slower in ME/CFS (Cohen’s \(d = 0.3\)–$ 0.7$ depending on task complexity), while accuracy was not meaningfully different from healthy controls (Lange et al. 2024). This dissociation—impaired speed with preserved accuracy—suggests that the underlying neural circuitry remains functionally intact but operates with reduced metabolic throughput, consistent with the energy limitation model developed later in this chapter.

1.2 Attention and Concentration

Attention and concentration deficits include difficulty sustaining attention, easy distractibility, impaired divided attention (multitasking), and reduced attentional capacity under stress.

Sustained attention shows a large effect size (\(g = -0.75\)) in the meta-analytic evidence (Aoun Sebaiti et al. 2022). A head-to-head comparison between ME/CFS and post-COVID patients found that 83.3% of ME/CFS patients showed sustained attention impairment versus 56.2% in post-COVID—a statistically significant difference suggesting that ME/CFS may produce more severe attentional deficits than Long COVID at comparable illness assessment points (Néstor Azcue et al. 2022).

1.3 Memory

Memory impairments encompass working memory deficits (holding information “online”), impaired short-term memory encoding, word-finding difficulties, and variable long-term memory retrieval.

Quantitative evidence shows moderate effect sizes across memory domains: visuo-spatial immediate memory \(g = -0.55\), episodic verbal memory (storage and retrieval) \(g = -0.55\) to \(-0.67\), and visual memory recovery similarly impaired (Aoun Sebaiti et al. 2022). Importantly, cognitive dysfunction in ME/CFS is independent of comorbid mood disorders and is not explained by poor effort or motivation—a finding replicated across the meta-analytic literature and consistent with the MCAM multi-site results (Lange et al. 2024) (Aoun Sebaiti et al. 2022).

ImportantHypothesis: Memory Triage Consequence

Certainty: 0.55.

Memory encoding is substantially more energy-expensive than memory retrieval, predicting that ME/CFS patients should show disproportionate encoding deficits relative to retrieval impairment—a pattern consistent with CNS energy triage.

Differential energy costs of memory operations. Hippocampal memory encoding requires long-term potentiation (LTP), involving NMDA receptor activation, calcium-dependent signaling cascades, new protein synthesis, and structural synaptic remodeling (Kandel, Dudai, and Mayford 2014). These processes are metabolically demanding: encoding a new memory trace requires de novo gene expression, dendritic spine growth, and synaptic protein trafficking. Retrieval, by contrast, reactivates existing synaptic patterns through pattern completion in CA3 networks—a process that uses established circuits without requiring new protein synthesis or structural modification (Dudai, Karni, and Born 2015).

Quantitative estimates suggest that LTP-associated protein synthesis increases local energy consumption by 30–50% above baseline in hippocampal neurons, whereas pattern completion during retrieval operates within normal metabolic parameters. Working memory maintenance in prefrontal cortex similarly requires sustained neuronal firing against inhibitory currents, creating continuous metabolic demand proportional to the number of items held in mind (Constantinidis et al. 2018).

Predicted pattern in ME/CFS. If CNS energy is limited, the brain should sacrifice high-cost encoding operations before low-cost retrieval operations—a “memory triage.” This predicts:

  • Encoding \(>\) retrieval impairment: Patients should show greater difficulty forming new memories than accessing old ones. Standardized testing should reveal disproportionate deficits on encoding-dependent tasks (learning new word lists, forming new associations) relative to recognition or cued recall of previously encoded material
  • Working memory \(>\) long-term retrieval: Sustained prefrontal firing for working memory maintenance is metabolically costly; retrieving consolidated long-term memories from distributed cortical stores is less so
  • Encoding degrades with exertion: During PEM, when CNS energy deficits intensify, new memory formation should decline more steeply than the ability to recall previously consolidated information
  • Context-dependent encoding failure: Encoding in metabolically demanding contexts (noisy environments, multitasking, social interaction) should fail preferentially, as these conditions compete for the limited energy budget

Supporting evidence. The meta-analysis by Sebaiti et al. (Aoun Sebaiti et al. 2022) documents memory impairment in ME/CFS with moderate effect sizes (\(g = -0.55\) to \(-0.67\)), but existing studies have not systematically separated encoding from retrieval. Clinical observation consistently reports that ME/CFS patients struggle more with forming new memories (“I can’t take in new information”) than with accessing established knowledge (“I remember things from before I got sick”). Patients frequently describe intact recognition (“I know I’ve seen this before”) with impaired free recall of recently encountered material—precisely the pattern predicted by encoding-selective energy limitation.

Treatment implications. If encoding is selectively impaired by energy limitation, compensatory strategies should emphasize: (1) reducing encoding load through external memory aids (notes, recordings, photographs) rather than relying on internal encoding; (2) scheduling new learning during peak energy windows; (3) using spaced repetition to distribute encoding costs across multiple low-demand sessions; (4) leveraging recognition over recall (multiple-choice formats, visual cues) when possible.

Limitations. This hypothesis has certainty 0.55. The differential energy cost of encoding versus retrieval is well established in neuroscience, but the specific prediction of disproportionate encoding impairment in ME/CFS awaits formal testing with paradigms designed to isolate encoding from retrieval. Existing neuropsychological batteries typically conflate encoding and retrieval in composite “memory” scores. Confounds include attention deficits (which impair encoding indirectly), medication effects, and sleep disruption (which impairs memory consolidation independently of encoding).

1.4 Executive Function

Executive function deficits present as planning and organization difficulties, impaired cognitive flexibility, reduced problem-solving ability, and difficulty with complex decision-making.

Meta-analytic evidence indicates a smaller effect size for executive function (\(g = -0.42\)) compared to processing speed and attention (Aoun Sebaiti et al. 2022), while instrumental functions (language, praxis) appear consistently preserved. This pattern—moderate executive dysfunction with severe processing speed impairment—is discussed further in the CNS energy triage model (Section Brain-Centric Model: CNS Primacy Not Demonstrated). Notably, the MCAM study found that complex tasks requiring both executive function and learning efficiency showed larger effect sizes (\(d = 0.6\)–$ 0.7$) than simple tasks (Lange et al. 2024), suggesting that standardized neuropsychological measures may underestimate the real-world executive burden when tasks are novel and unstructured.

2 Quantifying Cognitive Impairment: Population-Scale Evidence

While cognitive dysfunction in ME/CFS has been documented for decades, recent large-scale studies provide the most precise quantification to date, and parallel findings from post-COVID research offer convergent evidence.

2.1 ME/CFS Meta-Analytic Evidence

The systematic review by Aoun Sebaiti et al. (Aoun Sebaiti et al. 2022) synthesized 764 studies (1988–2019) using PRISMA and MOOSE guidelines. The meta-analytic effect sizes reveal a characteristic cognitive signature:

  • Reading speed: \(g = -0.82\) (\(p = 0.0001\))—the largest impairment
  • Sustained attention: \(g = -0.75\)
  • Visuo-spatial immediate memory: \(g = -0.55\) (\(p = 0.007\))
  • Episodic verbal memory: \(g = -0.55\) to \(-0.67\)
  • Executive function: \(g = -0.42\)
  • Instrumental functions: preserved

This profile—severe processing speed and attentional deficits, moderate memory impairment, relatively spared executive function on standardized tests, and intact instrumental function—is distinct from depression, anxiety, and neurodegenerative disease patterns, supporting ME/CFS cognitive dysfunction as a specific neurological entity rather than a nonspecific consequence of fatigue or mood disturbance.

2.2 Multi-Site Objective Assessment

The MCAM cognitive substudy (Lange et al. 2024), the largest US multi-site objective cognitive assessment in ME/CFS (\(n = 426\) across seven specialty clinics, 2013–2019), confirmed the meta-analytic findings using the CogState Brief Screening Battery. The key finding was the speed–accuracy dissociation: information processing speed was significantly slower in ME/CFS at most timepoints (Cohen’s \(d = 0.3\)–$ 0.5$ for simple tasks, \(d = 0.6\)–$ 0.7$ for complex tasks), while performance accuracy did not differ meaningfully between groups. This dissociation has diagnostic implications: speed-based cognitive measures are more sensitive than accuracy-based measures for detecting ME/CFS cognitive dysfunction.

A notable finding was that a single intense exercise session did not produce additional cognitive deficits beyond those attributable to the clinical visit itself (Lange et al. 2024). This somewhat counterintuitive result may reflect the fact that the cognitive assessment visit was itself sufficiently taxing to bring patients to their cognitive floor, making exercise-induced additional deterioration difficult to detect.

2.3 Post-COVID Cognitive Decline: Convergent Evidence

The COVID-19 pandemic has generated large-scale cognitive data that both parallels and illuminates ME/CFS findings:

Population-scale IQ-equivalent losses. Hampshire et al. (Hampshire et al. 2024) assessed 112,964 participants from the UK REACT study—the largest community-based study of post-COVID cognition. Cognitive deficits, expressed as IQ-scale equivalents, showed a graded dose–response relationship with illness severity:

  • Mild, resolved COVID (symptoms 4–12 weeks): \(~3\) IQ points (\(~-0.2\) SD)
  • Persistent symptoms / Long COVID (\(>=\) 12 weeks): \(~6\) IQ points (\(~-0.4\) SD)
  • ICU admission: \(~9\) IQ points (\(~-0.6\) SD)
  • Reinfection: additional \(~2\) IQ points per episode

Memory, reasoning, and executive function were the most sensitive domains. Earlier variants (original and Alpha) produced larger deficits than Omicron-era infections, and vaccination was associated with a small cognitive advantage. The Long COVID figure (\(\sim\) 6 IQ points) is directly relevant to ME/CFS: many Long COVID patients meeting post-exertional malaise criteria satisfy ME/CFS diagnostic criteria (Komaroff and Lipkin 2023), and likely fall at the more severe end of this distribution.

Objective cognitive slowing. Zhao et al. (Zhao et al. 2024) provided task-based confirmation in a multicenter study (UK and Germany, \(n = 270\)). Post-COVID patients showed reaction times approximately 3 standard deviations slower than healthy controls on simple reaction time tasks, with 53.5% exceeding 2 SD below normal. Fatigue and depression comorbidities did not fully account for the slowing—paralleling the independence of cognitive dysfunction from mood disorders in ME/CFS (Aoun Sebaiti et al. 2022).

Neuroimaging substrate. Douaud et al. (Douaud et al. 2022) provided the structural neuroimaging correlate using UK Biobank longitudinal data (\(n = 785\), before-and-after design). Even after predominantly mild COVID (96% non-hospitalized), infected individuals showed greater grey matter thickness reduction in the orbitofrontal cortex and parahippocampal gyrus (0.2–2% tissue loss in olfactory-related regions) and greater cognitive decline on complex tasks compared to matched controls. These structural changes in regions critical for memory encoding and executive function may underpin the cognitive deficits observed in both Long COVID and post-infectious ME/CFS.

ME/CFS vs. Long COVID: direct comparison. Azcue et al. (Néstor Azcue et al. 2022) conducted the most informative head-to-head comparison (\(n = 42\) ME/CFS, \(n = 73\) post-COVID). Both conditions shared a core pattern of reduced attention and slower processing, but ME/CFS patients showed significantly worse sustained attention (83.3% vs. 56.2% impaired) and visuospatial ability than post-COVID patients. The authors concluded that the conditions share overlapping pathology with different precipitating triggers—consistent with the post-infectious syndrome cluster model discussed in Section Speculative Cross-Disease Connections.

CautionSpeculation: Muscarinic GPCR Autoantibodies as Cognitive Modulators

Certainty: 0.35. Azcue et al. (2026) found that M1, M3, and M4 muscarinic acetylcholine receptor autoantibody titers positively correlated with verbal and working memory performance in ME/CFS patients (\(n=59\)) (N. Azcue et al. 2026). The direction—higher autoantibody titers associated with better cognitive performance—is unexpected and requires explanation. Three mutually compatible interpretations exist: (1) muscarinic AAbs may act as partial agonists, weakly stimulating receptors that would otherwise be insufficiently activated by diminished acetylcholine tone; (2) the correlation may reflect compensatory upregulation: patients with more severe cognitive impairment upregulate ACh receptors, and autoantibody production tracks receptor density rather than driving dysfunction; (3) the observed ELISA signal may capture non-pathogenic, low-affinity antibodies that correlate with intact cognitive function rather than causing it.

Falsifiable predictions: (a) Functional receptor assays (calcium flux, impedance) should demonstrate whether muscarinic AAbs from ME/CFS sera have agonistic, antagonistic, or null effects on receptor signaling. (b) If muscarinic AAbs are compensatory partial agonists, their depletion via immunoadsorption should transiently worsen verbal/working memory (a testable prediction with existing immunoadsorption trial data). (c) Muscarinic AAb titers should be inversely correlated with CSF acetylcholine metabolites (HVA/MHPG) if the compensatory hypothesis is correct.

Limitations: Single study, \(n=59\), not yet replicated. The positive direction is counterintuitive given the prevailing view that autoantibodies are generally pathogenic. CellTrend ELISA specificity concerns (see ch07 Autoimmunity in ME/CFS) apply. The finding may reflect assay artifacts rather than true receptor biology. Without functional validation, this remains a statistical observation only. Certainty 0.35 — cross-disease indirect evidence from Sjögren’s syndrome (muscarinic M3 AAbs as diagnostic biomarkers) provides mechanistic precedent for muscarinic receptor autoantibodies in chronic illness, but the correlation direction in ME/CFS is opposite to the expected pathological pattern.

WarningLimitation: Post-COVID Cognitive Data: Applicability to ME/CFS

The Hampshire et al. IQ-equivalent figures (Hampshire et al. 2024) apply to the general post-COVID population, not specifically to patients meeting ME/CFS criteria. The subset of Long COVID patients with post-exertional malaise likely has more severe cognitive impairment than the group average. Additionally, the IQ-equivalent expression converts composite cognitive scores to a familiar scale but does not represent direct IQ testing; the figures should be interpreted as population-level effect sizes rather than individual-level predictions. The Douaud et al. neuroimaging findings (Douaud et al. 2022) predate Omicron and may not fully represent current variant effects.

3 Social and Emotional Dysfunction

While less frequently discussed in clinical literature, social and emotional impairments represent significant sources of disability in ME/CFS and are direct consequences of the neurometabolic dysfunction documented above.

WarningLimitation: Social-Emotional Phenomenology: Clinical Observation, Not Empirical Research

The social disability descriptions in this section (social interaction as painful exertion, flat affect, relationship conflict as insurmountable barrier, environmental control as survival mechanism) are based on clinical observation and patient self-report. No published study has validated “social exhaustion,” “affective energy expenditure,” or “interpersonal metabolic cost” as measurable constructs in ME/CFS. The proposed neurobiological explanations (catecholamine depletion \(\to\) social withdrawal) are mechanistically plausible but represent inference, not demonstrated cause-and-effect. Alternative explanations—comorbid depression, social anxiety disorder, learned avoidance—have not been formally excluded in the populations described.

Note on evidence base: The detailed phenomenology described in this section is based primarily on extensive clinical observation and patient reports rather than systematic empirical research. While the underlying neurobiological mechanisms (catecholamine depletion, prefrontal hypometabolism, TPJ dysfunction) are well-documented (Walitt et al. 2024), the specific social and emotional manifestations described below await formal validation through patient surveys, qualitative research, and prospective studies. This section should be considered a synthesis of clinical observation with established neuroscience, not yet a body of peer-reviewed ME/CFS-specific research on social disability.

3.1 Social Interaction as Metabolically Demanding Activity

Social interaction requires the simultaneous coordination of multiple high-energy cognitive and neurological processes:

  • Language processing and production: Real-time comprehension, response formulation, word retrieval, and articulation
  • Working memory load: Tracking conversational context, remembering prior statements, maintaining coherent narrative threads
  • Executive function demands: Monitoring social cues, adjusting behavior in real-time, inhibiting inappropriate responses
  • Sensory integration: Simultaneous processing of facial expressions, vocal prosody, body language, and environmental context
  • Motor control for affect generation: Voluntary and involuntary facial expressions, eye contact, postural adjustments, vocal modulation
  • Reward system engagement: Dopamine-mediated reward processing that makes social interaction inherently reinforcing in healthy individuals

When ATP production is impaired and catecholamine levels are low (as documented in the NIH study (Walitt et al. 2024)), these processes cannot be sustained. The brain experiences social demands as it would physical exertion beyond capacity: as painful, threatening, something to avoid.

3.2 Clinical Presentation: Social Interaction as Painful Exertion

Many ME/CFS patients report that social interaction feels actively painful rather than merely tiring:

  • Subjective experience identical to being forced to perform physical exercise while exhausted
  • Approach characterized by “minimize the pain”—engage only as much as absolutely necessary
  • Absence of enjoyment or reward, even in interactions that would previously have been pleasurable
  • Duration often measured in minutes before exhaustion becomes overwhelming
  • Post-social crashes (cognitive and physical PEM) lasting hours to days

This pattern may persist for decades and often predates formal ME/CFS diagnosis, suggesting it reflects fundamental metabolic limitations rather than secondary depression or psychological withdrawal.

3.3 Flat Affect and Energy Conservation

Generating and displaying emotional affect is metabolically expensive:

  • Muscular activation: Smiling, animated facial expressions, and expressive body language require continuous motor control
  • Neurochemical substrates: Emotional expression requires adequate dopamine for motivation and reward signaling
  • Prefrontal-limbic coordination: Generating contextually appropriate affect requires coordination between multiple brain regions

When energy is scarce, the brain prioritizes survival functions over social signaling. The result is observable flat affect—patients appear emotionally unexpressive, disengaged, or “unhappy” even when not experiencing negative emotion. This is not conscious suppression or masking; it reflects genuine inability to generate the energetic and neurochemical processes required for emotional expression.

Emotional suppression in ME/CFS has been documented experimentally: patients show blunted electrodermal activity during emotion suppression tasks — a physiological flattening — paired with higher subjective distress (Rimes et al. 2016). The body cannot produce the normal physiological response, but the subjective experience remains intact. The patient feels everything; they simply cannot show it. This dissociation between internal experience and external expression is profoundly isolating: others perceive a flat, unresponsive person and infer absence of feeling, while the patient experiences the full range of human emotion but cannot produce the motor output to express it.

CautionSpeculation: Emotional Synchrony Failure as Prefrontal Mismatch Cost

Certainty: 0.40 (Tier 2, resting on convergent cross-domain evidence).

The inability to match others’ emotional tempo — emotional synchrony — may represent a distinct and underrecognized metabolic cost in ME/CFS. Neuroimaging evidence in healthy populations shows that when two people are emotionally congruent (both happy, both calm), the medial orbitofrontal cortex and ventromedial prefrontal cortex activate — regions linked to reward — making synchrony metabolically efficient because it requires no conflict resolution (Kühn et al. 2011). However, when emotional states are incongruent — the room is animated and the patient is depleted, someone directs cheerfulness at a person who feels nothing — the dorsolateral prefrontal cortex (DLPFC) activates to process the conflict between internal state and external expectation (Kühn et al. 2011). The DLPFC is the brain’s most metabolically expensive region.

For the person with ME/CFS, most social situations represent a continuous state of emotional mismatch. The room operates at a tempo the patient cannot match. The affect the patient can produce — flat, quiet, minimal — is incongruent with the affect the room expects. The DLPFC runs continuously, burning energy the patient does not have, trying to bridge a gap that cannot be bridged.

Facial mimicry — the automatic tendency to mirror others’ expressions — depends on intact medial prefrontal cortex. TMS experiments demonstrate this causally: activating the medial prefrontal cortex enhances facial mimicry; inhibiting it impairs it (Balconi and Canavesio 2013); (Balconi, Bortolotti, and Gonzaga 2011). The neural hardware that produces the smile expected in return for another’s warmth is the same frontal circuitry that is hypometabolic and hypoperfused in ME/CFS.

Fatigue directly impairs emotional contagion. Partial sleep deprivation in healthy subjects reduces emotional contagion — people feel less happiness observing happy faces, and their brains show reduced activation to emotional stimuli — even when facial muscle mimicry persists (Tamm et al. 2020). Total sleep deprivation reduces emotional empathy across multiple domains (Guadagni et al. 2014). In real-world settings, sleep-deprived physicians show measurably reduced empathy and prescribe fewer analgesics to patients in pain (Choshen-Hillel et al. 2022). If one night of poor sleep degrades emotional synchrony in healthy people, years of metabolic brain dysfunction — reduced cerebral glucose metabolism, impaired prefrontal function, depleted catecholamines — produce a brain operating in a state analogous to continuous partial sleep deprivation.

Consequence: The social synchrony deficit may explain why patients report that social interaction feels actively painful rather than merely tiring: the brain is continuously running a high-cost DLPFC conflict-resolution process that healthy people never experience because their energy reserves cover the synchrony cost automatically. This is a testable hypothesis — no published study has directly measured emotional contagion or emotional synchrony in ME/CFS, representing a genuine research gap with significant clinical relevance.

3.4 Interpersonal Consequences and Misattribution

The combination of social withdrawal and flat affect creates predictable interpersonal difficulties:

  • Misinterpretation as contempt or disinterest: Observers lacking context for the patient’s energy deficit often interpret flat affect and minimal engagement as disdain, superiority, or lack of care
  • Relationship damage: Colleagues, friends, and family members feel rejected, judged, or dismissed when the actual issue is metabolic incapacity
  • Emotional contagion: Others interacting with ME/CFS patients often become unhappy or uncomfortable themselves, unable to understand the patient’s apparent lack of positive affect
  • Inability to explain: The exhaustion that prevents social engagement also impairs the cognitive and communication capacity needed to explain the problem (“explaining why I’m too tired to talk requires energy to talk”)
  • Vicious cycle: Negative reactions from others increase the stress and energy demand of social interaction, further reducing capacity

Patients are frequently blamed for “attitude problems,” “not trying,” or “not caring” when the actual issue is neurometabolic failure to generate expected social signals.

3.5 The Communication Double-Bind

ME/CFS patients face an impossible situation regarding social interaction:

  • Employment and relationships require communication and social engagement
  • Communication and social engagement are painfully exhausting and worsen symptoms
  • Avoiding social interaction damages relationships and is misinterpreted as contempt
  • Explaining the difficulty requires the very communication capacity that is depleted
  • There is no winning strategy—only choices between different types of harm

3.6 Relationship Conflict as Insurmountable Barrier

The energy deficit affecting social interaction becomes critically limiting when relationships encounter even minor conflict or tension:

  • Conflict management requires peak cognitive resources: Navigating disagreements, processing emotions, formulating diplomatic responses, regulating one’s own reactions, and sustaining conversation through discomfort all require executive function, emotional regulation, and sustained attention—precisely the capacities most impaired in ME/CFS

  • Minor conflicts become insurmountable: What healthy individuals would consider trivial relationship friction (scheduling disagreements, differing preferences, minor miscommunications) becomes impossibly difficult to manage when cognitive and emotional resources are depleted

  • Relationship attrition: Friendships require ongoing maintenance, occasional conflict resolution, and emotional investment. When any conflict—however minor—exceeds available energy, relationships deteriorate and are eventually abandoned

  • Selection for low-maintenance relationships only: Only relationships requiring absolutely minimal effort, zero conflict, and no emotional complexity can be sustained. This severely restricts social connection to a vanishingly small subset of potential relationships

  • Inability to repair: Even when patients recognize that a relationship is worth preserving, they lack the energy to engage in the repair conversations necessary to resolve issues. The relationship fails not from lack of desire but from metabolic inability to execute repair

  • Compounding isolation: As relationships with any degree of complexity or occasional friction are abandoned due to inability to manage conflict, social networks contract to near-zero. Patients become profoundly isolated not from preference but from inability to meet the basic energy demands of relationship maintenance

  • Loss of deep connections: The inability to engage seriously in friendship—to invest emotional energy, navigate normal ups and downs, work through misunderstandings—means that only the most superficial relationships can survive. Patients lose access to the deep, meaningful connections that require tolerance for occasional difficulty

  • Present but disengaged: Even when patients are physically able to attend activities or gatherings, the constant underlying exhaustion limits how intensely they can engage with others. They are there in body but cannot fully participate emotionally or socially. This creates a perceptible distance that has no apparent reason—others sense the patient is “holding back” or “not really there,” but the actual cause (metabolic inability to engage more deeply) is invisible

  • Engagement intensity limited by energy, not desire: The degree of warmth, enthusiasm, investment, and genuine connection patients can offer is capped by available energy, not by their feelings toward others. Friendships that would otherwise be close remain distant because the patient cannot sustain the energy for deeper engagement, creating unexplained coldness that damages the relationship despite the patient’s genuine care

  • Inability to develop meaningful feelings: The energy limitation affects not only the expression of feelings but the development of feelings themselves. Emotional attachment, fondness, care, and affection require sustained interaction, shared experiences, emotional investment, and cognitive processing to develop. When energy constraints prevent this sustained engagement, feelings toward others remain shallow or fail to develop beyond superficial acquaintance. Patients find themselves unable to develop the deep care and emotional connection that would normally arise in friendships, creating a profound sense of emotional emptiness and isolation even when physically surrounded by potential friends

  • Social interactions as potential threats: The knowledge that any conflict or difficulty is insurmountable leads to a defensive posture where many interactions are experienced as opportunities to be aggressed. Since patients lack the energy to manage disagreement, navigate misunderstanding, or repair relationship damage, any interaction carries the risk of creating a problem they cannot solve. This produces preventive behavior—emotional guardedness, avoidance of deeper topics, reluctance to express needs or preferences—that further impedes the ability to connect with others. Patients become hypervigilant for potential conflict and withdraw preemptively to avoid situations they cannot metabolically handle, creating a self-protective isolation that others perceive as coldness or lack of trust

Clinical significance: The inability to manage even minimally conflictual relationships represents a major, under-recognized source of social disability in ME/CFS. This cannot be understated: patients lose friendships, partnerships, and entire social networks not because relationships are unimportant to them, but because the cognitive and emotional energy required to navigate normal relationship dynamics exceeds available capacity.

The defensive stance toward social interaction—experiencing interactions as potential threats and adopting preventive behaviors—is not paranoia or social anxiety disorder. It is a rational response to genuine incapacity. When any disagreement or misunderstanding represents an insurmountable problem due to energy deficit, hypervigilance and preemptive withdrawal become adaptive survival strategies, though they further entrench isolation.

Critically, the feeling alone is sufficient to drive protective behavior. Patients do not need to consciously analyze the risk or make deliberate decisions to withdraw—the subjective experience of interactions as threatening automatically triggers defensive responses. This emotional reality shapes behavior independent of objective threat assessment, making the social disability self-reinforcing: the feeling of vulnerability produces protective isolation, which prevents connection, which maintains isolation.

3.7 Environmental Control as Survival Mechanism

The energy deficit necessitates a level of environmental control that is incompatible with normal social spontaneity and fundamentally at odds with what others experience as “the joy of life”:

  • Need for high control: Patients require predictability, structure, and control over their environment to prevent energy-depleting surprises. Unforeseen events, changes in plans, unexpected social demands, or environmental chaos each represent potential energy expenditures that may trigger crashes

  • Incompatibility with spontaneity: What healthy individuals experience as joyful spontaneity—surprise visits, impromptu plans, playful chaos, unexpected adventures—registers for ME/CFS patients as threatening unpredictability requiring energy they do not have

  • Others’ joy as patient’s stress: When others behave in ways they enjoy—being spontaneous, playful, or socially unpredictable—they create a more energetically demanding environment for patients. The very behaviors that make life feel vibrant and enjoyable for healthy people increase the metabolic burden and stress for patients beyond what they can afford to manage

  • Inability to “let go”: Patients cannot easily relax control over their environment because this control is almost vital to avoid exhaustion and crashes. What appears as rigidity, controlling behavior, or inability to be spontaneous is actually a survival mechanism—without environmental control, energy expenditure becomes unpredictable and unmanageable

  • Social consequences: Others perceive the need for control as rigidity, inflexibility, being “no fun,” or being controlling. Patients are seen as unable to enjoy life, overly cautious, or anxiety-driven when the actual issue is metabolic necessity

  • The paradox of joy: Patients are often told to “relax,” “let go,” “be spontaneous,” or “just have fun”—but these very behaviors require energy reserves they do not possess. The inability to engage in joyful spontaneity is not psychological resistance but physiological impossibility

The fundamental incompatibility: Normal social life thrives on a degree of unpredictability, spontaneity, and flexibility that ME/CFS patients cannot metabolically afford. The environmental control necessary for survival (avoiding crashes, managing energy) is experienced by others as joyless rigidity. Patients must choose between:

  • Maintaining control to prevent crashes (perceived as controlling, rigid, unable to have fun)
  • Allowing spontaneity to please others (risking energy depletion, crashes, worsening disability)

There is no middle ground when energy reserves are this limited. The choice to maintain control is not preference or personality—it is metabolic necessity masquerading as behavioral rigidity.

The Energy Poverty Analogy. The psychological state of ME/CFS patients living with severe energy deficit is analogous to the lived experience of people in extreme financial poverty:

  • Constant precariousness: Just as very poor people live under constant financial stress knowing that any unforeseen expense—even an insignificant 20–50€ debt—could trigger a cascade of catastrophic consequences (eviction, utility shutoff, inability to afford food or medical care), ME/CFS patients live under constant metabolic stress knowing that any unforeseen energy expenditure can trigger crashes that eliminate function for days, weeks, or permanently

  • Inability to absorb shocks: People with financial reserves can absorb unexpected expenses without crisis. People with energy reserves can absorb unexpected demands without crashing. Those living at the edge—whether financial or metabolic—have no buffer. Every unexpected demand is a potential catastrophe

  • Hypervigilance as survival: The poor must constantly monitor their finances, avoid any unnecessary spending, and maintain rigid control over their budget to prevent disaster. ME/CFS patients must constantly monitor their energy, avoid any unnecessary expenditure, and maintain rigid control over their environment to prevent crashes. Both behaviors appear as anxiety or rigidity to those with adequate resources but are rational responses to genuine scarcity

  • Incomprehension from the resourced: People with financial security cannot understand why the poor seem so anxious about “small” expenses or why they cannot “just relax” about money. People with energy reserves cannot understand why ME/CFS patients seem so anxious about “small” demands or why they cannot “just relax” and be spontaneous. The invisible nature of the deficit makes the defensive behavior appear irrational

  • Poverty trap dynamics: Financial poverty creates conditions that perpetuate poverty (stress impairs decision-making, lack of resources prevents investment in improvement). Energy poverty creates conditions that perpetuate energy deficit (stress depletes energy, lack of reserves prevents activities that might improve capacity). Both are self-reinforcing traps difficult to escape

  • Judgment and blame: The poor are blamed for being “too cautious,” “no fun,” unable to enjoy life, overly anxious, or having a scarcity mindset. ME/CFS patients are blamed for being controlling, rigid, unable to be spontaneous, overly anxious, or having a fearful personality. In both cases, the behavior is adaptive to genuine scarcity, not a character flaw

Clinical significance: Understanding ME/CFS energy management through the lens of poverty economics helps clarify why patients exhibit behaviors that appear rigid or controlling to healthy observers. The “energy poverty” framework explains the hypervigilance, need for control, inability to tolerate unpredictability, and constant stress as rational adaptations to living at the metabolic edge. Just as telling someone in extreme financial poverty to “stop worrying about money and have fun” is tone-deaf and unhelpful, telling ME/CFS patients to “relax,” “let go,” or “be spontaneous” fundamentally misunderstands their metabolic reality.

Even when patients can attend activities, the pervasive exhaustion creates an invisible barrier to genuine engagement. Others perceive this as emotional distance, lack of interest, or “holding back”—but it reflects metabolic incapacity, not psychological withdrawal. The patient may desperately want to engage more warmly, more deeply, with more enthusiasm and investment, but the energy simply does not exist. This creates relationships that feel inexplicably cold or distant despite no apparent reason, as the actual limitation (energy deficit) is invisible to observers.

This pattern is distinct from social anxiety or avoidant personality disorder—patients often desperately want connection but physiologically cannot sustain the energy expenditure relationships require, particularly when any degree of conflict or complexity arises.

3.8 The Defensive Shift: When Energy Depletion Produces Criticality

Beyond quiet withdrawal and flat affect, energy depletion predictably produces a shift toward criticism, negativity, and defensive reactivity. This is not a personality trait — it is a direct consequence of prefrontal metabolic constraint.

The dorsolateral prefrontal cortex (dlPFC) is the seat of cognitive control: the ability to override automatic responses, to regulate emotion, to select the socially appropriate output from a range of possible responses. When the dlPFC is underpowered due to cerebral hypometabolism (Siessmeier et al. 2003), the filter between thought and speech thins. What a healthy brain would think and not say, the ME/CFS brain thinks and says — because the inhibitory circuit that would have caught the impulse is running on empty.

This is compounded by a second mechanism: cognitive load narrows attention. The more depleted a system becomes, the more it narrows processing to what is most urgent. For a brain in energy crisis, what is most urgent is threat — real or perceived. The result is a cognitive bias toward the negative. Mental fatigue research demonstrates that depleted individuals become less capable of nuanced processing, defaulting instead to heuristic, categorical judgments — a pattern consistent with the broader ego-depletion literature in which self-regulation resources govern the capacity for controlled social cognition (Gailliot et al. 2007); (Baumeister et al. 1998). This is a conserved biological response to resource scarcity, not a characterological tendency.

The depleted brain reverts to what is computationally cheapest: heuristic, categorical, threat-oriented processing. It scans for what is wrong because scanning for what is right is energetically expensive. It interprets ambiguity as hostility because giving the benefit of the doubt requires cognitive effort. It snaps at small provocations because inhibiting the snap requires prefrontal resources that are not available. The evolutionary logic follows directly from the sickness-behaviour framework documented below: when an organism is in a state of metabolic crisis — injured, infected, starving — the brain shifts from exploration to defence, from curiosity to vigilance, from cooperation to self-protection. The ancient subcortical circuits, honed for survival, take priority when metabolic resources are scarce; the energy-expensive prefrontal functions — nuanced judgment, emotional regulation, social generosity — are downgraded. This is not a temporary state: in ME/CFS, the energy crisis is the disease. The defensive posture is baseline.

CautionSpeculation: Masking as Metabolic Cost

Certainty: 0.35 (Tier 2, based on self-reported clinical observation).

Many patients with ME/CFS report masking their symptoms in social settings — suppressing visible signs of pain, forcing engagement, performing normalcy. While masking has not been studied quantitatively in ME/CFS, its metabolic logic is consistent with the broader evidence on sustained emotion regulation. The ego-depletion paradigm demonstrates that acts of self-control impair subsequent self-control and have a measurable metabolic cost (Gailliot et al. 2007); (Baumeister et al. 1998). Extended masking — maintaining a socially normative presentation over the course of a conversation or visit — would constitute sustained self-regulation of the kind known to deplete limited resources, on top of the cognitive load of the interaction itself and the sensory load of the environment. When the mask slips — when the tone sharpens, when patience runs out — this represents not an underlying “difficult personality” but the exhaustion of the energy budget for self-presentation, at which point what remains is the unfiltered output of a brain in metabolic deficit.

Consequence: Masking should be recognized as a distinct energy cost in ME/CFS social disability — the effort of appearing normal depletes the same metabolic resources needed for conversation itself. Reducing the expectation to mask (by creating environments where flat affect and quietness are accepted) may be a meaningful energy-conserving intervention, though no trial has tested this directly.

In ME/CFS, under stress and fatigue, attention narrows to central, focal stimuli and peripheral awareness degrades. This is the Easterbrook effect: as arousal or load increases, the range of cues an organism can process shrinks (Easterbrook 1959). Applied to social situations, this means the depleted person misses peripheral social information — subtle shifts in expression, changes in tone, body language that signals a shift in conversation. They are processing less of the social environment, not because they are not paying attention, but because their attentional bandwidth has contracted. This narrowing has cumulative social consequences: the person who misses peripheral cues responds less appropriately, misreads situations more often, and appears socially clumsy or disconnected.

3.9 Neurobiological Basis

The social and emotional impairments described above are explained by the documented neurological abnormalities:

  • Catecholamine depletion: Low dopamine and norepinephrine impair both reward processing (making social interaction unrewarding) and the motivation to engage socially (Walitt et al. 2024). BH4 depletion compromises tyrosine hydroxylase activity, directly limiting catecholamine synthesis capacity (Williams et al. 2025).
  • Prefrontal hypometabolism: Reduced energy availability in prefrontal regions impairs the executive functions required for social cognition (Siessmeier et al. 2003). Self-regulation — emotional control, impulse inhibition, careful word choice — draws on the same limited prefrontal metabolic resources that are compromised in ME/CFS. Experimental studies in healthy populations demonstrate that acts of self-control measurably reduce blood glucose and impair subsequent self-regulation, establishing that social comportment depends on a depletable metabolic resource (Gailliot et al. 2007); (Baumeister et al. 1998).
  • Effort-reward miscalculation: Reduced dopaminergic tone biases basal ganglia computation toward effort aversion — social interaction is computed as high-cost, low-reward activity rather than the inherently reinforcing experience it is for healthy individuals (Miller et al. 2014); (Treadway et al. 2012); (Salamone and Correa 2012). This is reinforced by predictive processing models in which fatigue increases the brain’s prior expectation of effort cost, making engagement feel prohibitively expensive before it begins (Greenhouse-Tucknott et al. 2022).
  • Cerebral hypoperfusion: Reduced blood flow limits the brain’s capacity to sustain the metabolic demands of complex social processing.
  • ATP depletion: Fundamental energy insufficiency makes any sustained cognitive activity painful. Cognitive exertion increases brain ATP demand by 10–20% above baseline, and the brain has minimal energy reserves (Jamadar et al. 2025).

3.10 Clinical Significance

Social withdrawal and flat affect in ME/CFS are metabolic symptoms, not personality traits, character flaws, or pure psychiatric conditions.

The evolutionary framework of sickness behaviour provides the biological context: across species, the coordinated suite of fatigue, social withdrawal, anhedonia, hyperalgesia, and irritability that accompanies infection serves to redirect energy away from social interaction and toward immune function (Morris et al. 2013). When an animal is sick, it withdraws from the group, stops grooming, stops responding to social signals, becomes less tolerant of approach, and may become aggressive if pushed — each behaviour conserving energy for immune defence by eliminating non-essential expenditure. In acute infection this programme runs for days and then switches off. In ME/CFS, chronic inflammatory signalling keeps it engaged far beyond any acute trigger (Vollmer-Conna et al. 2004). The patient is not choosing withdrawal; the patient’s brain is running an evolutionarily conserved energy-conservation programme that never receives the shutoff signal.

The irritability that accompanies sickness behaviour is adaptive: an animal that is sick and weak must keep threats at a distance because it cannot fight or flee. The low threshold for defensive reaction — the sharp response to minor intrusion — serves as a perimeter alarm. This pattern from sickness behaviour maps directly onto the clinical observation that ME/CFS patients become more critical, defensive, and reactive as energy reserves deplete: the affective change is not a personality defect but a conserved biological response to resource scarcity.

Beyond withdrawal and irritability, energy depletion produces a broader psychosocial syndrome for which converging evidence exists across multiple research domains. Sleep loss in healthy populations — a well-characterized model of acute energy deficit — reduces willingness to help others, deactivates the brain’s social-cognition network (medial prefrontal cortex, temporoparietal junction, inferior frontal gyrus), and at population scale produces measurable drops in charitable giving (Ben Simon et al. 2022). While the specific mechanisms of energy deficit differ between acute sleep deprivation and chronic ME/CFS, the neural circuitry affected — social-cognition and prefrontal networks — overlaps substantially with the regions showing hypometabolism and reduced activation in ME/CFS. Post-infectious fatigue reduces reward sensitivity — the brain assigns lower motivational priority to activities that would normally feel worth the effort, independent of effort cost (Scholing et al. 2025). The conservation-withdrawal framework from psychosomatic medicine describes a behavioural state in which the self withdraws from engagement, narrows its circle of trust, intensifies self-concern, and redirects all remaining resources toward self-protection (Ironside 1980). Under fatigue, perceptual narrowing — the Easterbrook effect — reduces the range of social cues a person can process, degrading peripheral awareness of subtle expressions, tone shifts, and body language (Easterbrook 1959). Taken together, the convergent evidence predicts that the person with ME/CFS becomes less generous, more withdrawn, less motivated by reward, more self-focused, and processes a narrower slice of the social world — not because of who they are, but because their brain has been forced into energy-conservation mode.

Consequence: The full psychosocial signature of energy depletion — social withdrawal, reduced prosociality, emotional flattening, defensive irritability, reduced reward sensitivity — is a predictable consequence of the metabolic dysfunction at the core of ME/CFS. This reframes what is often attributed to personality or psychiatric comorbidity as biologically conserved energy-conservation responses.

For patients: If social interaction feels painful, if you feel no enjoyment in activities that once brought pleasure, if others tell you that you seem “unhappy” or “unengaged”—these are recognized manifestations of the neurometabolic dysfunction documented in ME/CFS research. This is not your fault. You are not antisocial, cold, or broken. Your brain lacks the energy and neurochemical substrates required for normal social and emotional functioning. The fact that conversation and social interaction are recognized PEM triggers, listed alongside physical exercise, reflects the same underlying reality: cognitive and emotional exertion are metabolically real, and the energy deficit does not distinguish between physical and social demands.

For clinicians and caregivers: Patients who appear disengaged, flat, or “unmotivated” for social interaction are not exhibiting “behavioral problems.” They are conserving severely limited energy reserves. Pressure to “be more social” or “act happier” is equivalent to demanding that someone with severe anemia run a marathon. The physiology does not support the demand.

For researchers: The social and emotional dysfunction in ME/CFS deserves systematic study alongside more commonly recognized cognitive domains. Validated instruments for assessing “social exhaustion,” “affective energy expenditure,” and “interpersonal metabolic cost” would help quantify this significant source of disability.

3.11 The Pre-Diagnosis Experience

Before diagnosis — sometimes years before — the exhaustion, social withdrawal, irritability, and inability to keep up are felt but not understood. The person does not know why socializing has become so punishing. They do not know that their mitochondria are failing. They only know that being around people makes them feel worse, and that fighting through it only deepens the crash.

Without a biological explanation, the brain does what brains do with unexplained distress: it looks for causes in the environment. These people are draining me. That friend is too demanding. That group is too stressful. I must be an introvert. I must not like these people anymore. Maybe I am depressed. The interpretations that emerge from energy depletion — threat scanning, negativity bias, defensive posture — become the story the person tells themselves about why they are withdrawing.

They begin to isolate. Not because isolation is what they want, but because isolation is the only pattern that reliably reduces symptoms. The cost-benefit analysis, run without conscious awareness, converges on a single strategy: spend less time with people who require energy, more time with people who demand less. The quiet friend who does not need constant engagement. The relative who sits in comfortable silence. The online space where participation is optional and asynchronous. The person who gives attention without asking for performance in return.

This is rational behaviour in the context of an unrecognized metabolic disease. But without the diagnosis, it looks like something else — social anxiety, avoidance, personality change, relationship deterioration. The person is not choosing solitude. They are gravitating toward the only social environments their energy budget can sustain. The isolation is not the problem. It is the solution to a problem that has not yet been named.

The person with undiagnosed ME/CFS is also running a continuous, conscious energy management protocol that healthy people never need to run. Every few seconds, an internal computation: how much energy do I have, how much will the next minute demand, what is the least costly way to remain present? The patient tracks sensory load, noise levels, visual complexity, number of speakers. They monitor autonomic status — heart rate, breathing, the early warning signals of PEM. They weigh the cost of every potential action. Speak now, or save the energy for standing up later. Defend against that comment, or let it go and save the ATP. When the energy runs too low for even this management — when the monitoring itself becomes too expensive — the system defaults to its cheapest mode: defence. Every input is a potential threat, every question a demand, every smile a withdrawal request on an account with nothing in it. The personality that emerges — critical, distant, reactive — is not the person. It is the person stripped of the metabolic resources required to be generous.

CautionWarning: Harmful Advice: The “Power of Positive Thinking”

Some clinicians, family members, friends, and caregivers, despite good intentions, offer advice to ME/CFS patients that is not only unhelpful but actively harmful and insulting:

The harmful message:

  • “You need to be more optimistic”
  • “Believing you will get better will make you better”
  • “Your attitude is holding you back”
  • “The mind-body connection means positive thinking can heal you”
  • “You need to stop focusing on your symptoms”

Why this is harmful:

  • Blames the patient for their illness: This framing implies that patients are sick because they are not trying hard enough to think positively, placing moral responsibility for a metabolic disease on the patient’s psychological state

  • Contradicts objective evidence: The 2024 NIH study documented measurable neurological abnormalities—low catecholamines, TPJ dysfunction, cerebral hypoperfusion, T-cell exhaustion. These are not created or maintained by “negative thinking” and cannot be resolved by “optimism”

  • Ignores patient experience: Decades of lived experience show that ME/CFS patients who maintain hope, who try every treatment, who remain optimistic, still worsen or remain severely ill. The disease trajectory is independent of psychological attitude

  • Dismissive and insulting: Telling someone with documented metabolic dysfunction that their attitude is the problem is equivalent to telling a diabetic that believing their pancreas works will make it produce insulin. It dismisses the physiological reality of the disease

  • Adds psychological burden: Patients already carry immense guilt and self-blame (“Why can’t I do what I used to do? Why am I letting everyone down?”). Being told their illness persists because they are not optimistic enough adds psychological torment to physical suffering

  • Prevents appropriate treatment: When clinicians attribute symptoms to psychological factors, they fail to investigate and treat the underlying metabolic, immunological, and neurological dysfunction

  • Gaslighting: This advice constitutes medical gaslighting—denying the patient’s lived reality and documented physiological abnormalities in favor of a psychosomatic explanation that places blame on the patient

The reality:

  • ME/CFS patients are not sick because they lack optimism
  • Positive thinking does not reverse catecholamine depletion, mitochondrial dysfunction, or immune exhaustion
  • Many patients maintain hope and optimism for decades while their condition worsens—their attitude did not prevent deterioration
  • The mind-body connection exists, but it does not mean that metabolic diseases can be thought away
  • Encouraging appropriate pacing, realistic expectations, and acceptance of limitations is more therapeutic than false promises that optimism will cure metabolic dysfunction

For clinicians: If you find yourself telling ME/CFS patients to “be more optimistic” or attributing their symptoms to psychological factors, recognize that you are:

  • Contradicting objective research evidence
  • Causing psychological harm
  • Failing to provide appropriate medical care
  • Perpetuating the decades of medical gaslighting that has defined ME/CFS patient experience

The appropriate clinical response is to acknowledge the physiological reality of the disease, validate the patient’s experience, support symptom management and pacing, and avoid placing the burden of recovery on the patient’s psychological state.

4 Fluctuation and Post-Exertional Cognitive Malaise

A characteristic feature distinguishing ME/CFS cognitive dysfunction from other conditions is its marked fluctuation, including hour-to-hour and day-to-day variability, worsening with physical, cognitive, or emotional exertion, delayed deterioration (cognitive “payback”), and improvement with rest that rarely returns to premorbid baseline.

5 CNS Energy Crisis as Primary Event

The selective energy dysfunction hypothesis (Section Selective Energy Dysfunction Hypothesis) proposes that neurological symptoms in ME/CFS reflect primary CNS energy failure rather than downstream effects of systemic dysfunction. Several observations support this framing:

  • CNS-specific findings: Neuroinflammation (45–199% elevation in key regions (Nakatomi et al. 2014)), catecholamine deficiency in CSF, and regional hypometabolism are documented in the CNS specifically (Zhu et al. 2025), not as reflections of peripheral dysfunction

  • Preserved autonomous processes: Hair growth, nail growth, and basal cardiac automaticity—processes that operate locally without CNS coordination—remain intact even in severe ME/CFS, arguing against global metabolic failure

  • Demand-response failure: The pattern of preserved baseline function with impaired challenge response (91–100% show abnormal CBF reduction during orthostatic challenge (Novak et al. 2022)) is consistent with a CNS coordination bottleneck rather than peripheral end-organ dysfunction

  • Cognitive triage hierarchy: The observation that complex cognition and executive function (“brain fog”) are affected before motor coordination or sensory processing suggests an energy triage system that sacrifices “luxury” cognitive functions first

  • Astrocyte vulnerability: The brain’s unique metabolic architecture—with neurons depending on astrocytes for lactate via the ANLS (Section Brainstem Glial Senescence as a Self-Reinforcing Autonomic Trap)—may create CNS-specific vulnerability not present in peripheral tissues with direct glucose access (Pellerin and Magistretti 1994) (Magistretti and Allaman 2018) (Xu et al. 2026)

This perspective has treatment implications: interventions that bypass CNS coordination (e.g., direct-acting autonomic agents like midodrine) or that specifically target CNS metabolism may be more effective than peripheral mitochondrial support alone.

WarningLimitation: Brain-Centric Model: CNS Primacy Not Demonstrated

Multiple sections of this chapter frame CNS dysfunction as the “primary bottleneck” or “upstream driver” of ME/CFS symptoms. This causal hierarchy has not been established:

  • No longitudinal study has demonstrated that neurological abnormalities precede peripheral immune, metabolic, or autonomic dysfunction in ME/CFS onset.
  • Alternative causal orderings are equally plausible: primary immune dysfunction driving secondary neuroinflammation, or primary metabolic failure producing secondary CNS changes.
  • The “demand-response failure” pattern (preserved baseline with impaired challenge response) is also predicted by peripheral models (e.g., mitochondrial dysfunction limiting peak capacity).
  • Pharmacological bypass evidence (midodrine efficacy) supports autonomic involvement but does not establish CNS primacy—peripheral autonomic failure would produce identical responses.
  • The cascade model, kindling hypothesis, and energy triage model are internally consistent but rest on untested causal assumptions; internal consistency is not evidence of causal direction.

6 CNS Energy Triage: A Hierarchical Model of Brain Fog

CautionSpeculation: CNS Energy Triage Hypothesis

Certainty: 0.35. The brain may operate a hardwired energy prioritization system during metabolic scarcity, explaining why ME/CFS cognitive dysfunction follows a characteristic pattern rather than producing uniform degradation across all domains.

Neuroscience of brain energy prioritization. The human brain comprises approximately 2% of body mass yet consumes 20–25% of resting metabolic energy, with goal-directed cognition requiring only an additional \(\sim\) 5% above resting homeostatic costs (Jamadar et al. 2025). This tight energy budget means that even modest metabolic deficits—such as those produced by impaired astrocyte-neuron lactate shuttling (Section Brainstem Glial Senescence as a Self-Reinforcing Autonomic Trap)—could disproportionately affect the most energy-intensive neural processes.

Not all brain regions have equal metabolic demands. The prefrontal and frontoparietal association cortices, which support executive function, cognitive flexibility, and novel problem-solving, exhibit the highest relative metabolic cost—defined as energy utilization exceeding baseline activity levels (Jamadar et al. 2025). In contrast, brainstem nuclei governing vital functions (respiration, cardiovascular regulation, arousal) and primary sensory cortices operate with lower relative metabolic overhead, relying on phylogenetically older, more energy-efficient circuits.

Evidence from metabolic disruption models.

Cross-disease convergence. An independently developed brain energy disorder framework for autism spectrum disorder proposes an identical energy-saving adaptation: prefrontal and association cortices — with the highest relative metabolic cost — are sacrificed first under energy constraint, while phylogenetically older circuits are preserved (Blagojevic-Stokic et al. 2026). This convergence across diagnostic boundaries suggests that hierarchical cognitive shutdown may be a general property of CNS energy scarcity rather than a disease-specific phenomenon (Section Brain Energy Metabolism: Cross-Disease Convergent Framework).

Two natural experiments demonstrate hierarchical cognitive shutdown under energy scarcity:

  • Hypoglycemia: Acute reduction in brain glucose supply impairs complex higher-order cognitive processes at higher glucose thresholds and to a greater extent than lower-level functions. Executive functions show large effect sizes (\(d > 0.8\)) during hypoglycemia (Graveling, Deary, and Frier 2013), consistent with the prefrontal cortex’s elevated metabolic sensitivity.

  • Anesthesia: General anesthetics produce a hierarchical disconnection pattern in which prefrontal and association cortices are affected first, while primary sensory processing and thalamocortical connectivity remain preserved. Mashour characterizes this as preferential failure of “rich club” network hubs with greater metabolic demands (Mashour 2024)—an “airport in a snowstorm” analogy where the most connected, most metabolically expensive nodes fail first.

Furthermore, prolonged cognitive work causes glutamate accumulation specifically in the lateral prefrontal cortex, making further executive function activation progressively more metabolically costly (Wiehler et al. 2022). This suggests a built-in mechanism by which the brain curtails its most expensive operations when metabolic capacity is strained.

Application to ME/CFS. We speculate that ME/CFS produces a chronic version of this triage state. If total available CNS energy is reduced—whether through astrocyte dysfunction, reduced cerebral blood flow, or neuroinflammation—the brain may engage the same prioritization hierarchy that normally activates only during acute metabolic crises. The proposed triage order, from most to least protected, would be:

  • Brainstem vital functions (preserved even in severe ME/CFS)
  • Basic sensory processing (usually intact)
  • Language comprehension (impaired only in severe cases)
  • Motor coordination (degraded in moderate-severe disease)
  • Memory consolidation (commonly affected)
  • Executive function and cognitive flexibility (affected early, often prominently)

This maps to the formal energy triage hypothesis developed in Section Selective Energy Dysfunction Hypothesis (specifically Hypothesis CNS Energy Triage), but here we emphasize the clinical neuroscience basis rather than the mathematical framework.

An important caveat from meta-analytic evidence. The largest meta-analysis of cognitive impairment in ME/CFS (33 studies, \(n = 1{,}086\)) reveals that the observed pattern is more nuanced than a simple “executive function fails first” model (Aoun Sebaiti et al. 2022). Processing speed shows the largest impairment (\(g = -0.82\)), followed by sustained attention (\(g = -0.75\)), then memory domains (\(g = -0.55\) to \(-0.67\)), with executive function showing a smaller effect (\(g = 0.42\)) and instrumental functions preserved. This is important: processing speed is more impaired than executive function on standard neuropsychological measures.

This apparent discrepancy may be reconciled by recognizing that processing speed is a global measure of neural efficiency degraded by any reduction in brain energy delivery, not a specific cognitive tier. It reflects the overall metabolic throughput of cortical circuits rather than a discrete cognitive function. Additionally, standardized tests of executive function (e.g., Trail Making Test Part B) involve relatively routinized operations that may not capture the full metabolic cost of genuinely novel, unstructured problem-solving. The energy triage model predicts that novel, complex, integrative cognitive operations fail first—not necessarily the specific neuropsychological domain labeled “executive function” in test batteries.

Testable predictions. If the CNS energy triage model is correct, the following should hold:

  • Novel tasks are impaired more than practiced routines at matched difficulty
  • Working memory (high-energy encoding) fails before recognition memory (lower-energy pattern completion), as formalized in Hypothesis Hierarchical Memory Impairment from Energy Triage
  • Cognitive hierarchy of impairment maps to regional metabolic demand on FDG-PET
  • Severity progression follows the triage order: mild ME/CFS shows primarily executive/speed deficits; severe ME/CFS additionally shows language and motor involvement
  • Interventions that bypass energy-expensive processing (routinization, external cognitive scaffolding) should preferentially improve function

Treatment implications. If the brain operates in chronic triage mode, the therapeutic strategy shifts from “try harder” to “reduce the load”: (1) routinize daily activities to shift them from energy-expensive prefrontal control to energy-efficient basal ganglia automaticity; (2) use external cognitive scaffolding (lists, alarms, decision templates) to offload executive demands; (3) schedule cognitively demanding tasks during peak energy windows when triage thresholds are temporarily relaxed; (4) explore metabolic interventions (ketone supplementation, cerebral blood flow optimization) that may expand the total energy budget and raise triage thresholds across all tiers.

Limitations. This hypothesis faces several challenges: (1) the meta-analytic evidence does not cleanly support executive function as the most impaired domain (Aoun Sebaiti et al. 2022); (2) the triage hierarchy has not been directly tested in ME/CFS with tasks specifically designed to probe each tier; (3) alternative explanations for the cognitive pattern exist, including neuroinflammation-mediated cytokine effects on specific circuits (Bansal et al. 2025), tryptophan pathway diversion, and autonomic-mediated cerebral hypoperfusion; (4) the model may oversimplify what is likely a multi-mechanism process. The triage framework should be understood as one contributing mechanism among several, not a complete explanation for ME/CFS cognitive dysfunction.

References

Aoun Sebaiti, Mehdi, Mathieu Hainselin, Yannick Gounden, Carmen Adella Sirbu, Slobodan Sekulic, Lorenzo Lorusso, Luis Nacul, and François Jérôme Authier. 2022. “Systematic Review and Meta-Analysis of Cognitive Impairment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).” Scientific Reports 12 (1): 2157. https://doi.org/10.1038/s41598-021-04764-w.
Azcue, Néstor, Juan Carlos Gómez-Esteban, Miriam Acera, Beatriz Tijero, Teresa Fernández, Miren Ayo-Mentxabaleta, Marta M de Pancorbo, Jesús Cortés, and Ager Muñoz-Lopetegi. 2022. “Brain Fog of Post-COVID-19 Condition and Chronic Fatigue Syndrome, Same Medical Disorder?” Journal of Translational Medicine 20: 569. https://doi.org/10.1186/s12967-022-03764-2.
Azcue, N., A. Prada, R. Del Pino, M. Acera, T. Fernández-Valle, N. Ayo-Mentxakatorre, T. Pérez-Concha, et al. 2026. “Involvement of Autoantibodies Against G Protein-Coupled Receptors in Post-COVID Condition and Chronic Fatigue Syndrome.” Scientific Reports 16. https://doi.org/10.1038/s41598-026-49131-9.
Balconi, Michela, Adriana Bortolotti, and Ludovico Gonzaga. 2011. “Emotional Face Recognition, EMG Response, and Medial Prefrontal Activity in Empathic Behaviour.” Neuroscience Research 71 (3): 251–59. https://doi.org/10.1016/j.neures.2011.07.1833.
Balconi, Michela, and Ylenia Canavesio. 2013. “High-Frequency rTMS Improves Facial Mimicry and Detection Responses in an Empathic Emotional Task.” Neuroscience 236: 12–20. https://doi.org/10.1016/j.neuroscience.2013.01.035.
Bansal, Amolak S., Katie A. Seton, Floyd C. Engelbrecht, et al. 2025. “Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Aetiology and Potential Treatments.” International Journal of Molecular Sciences 26 (5): 1896. https://doi.org/10.3390/ijms26051896.
Baumeister, Roy F, Ellen Bratslavsky, Mark Muraven, and Dianne M Tice. 1998. “Ego Depletion: Is the Active Self a Limited Resource?” Journal of Personality and Social Psychology 74 (5): 1252–65. https://doi.org/10.1037/0022-3514.74.5.1252.
Ben Simon, Eti, Raphael Vallat, Aubrey Rossi, and Matthew P Walker. 2022. “Sleep Loss Leads to the Withdrawal of Human Helping Across Individuals, Groups, and Large-Scale Societies.” PLoS Biology 20 (8): e3001733. https://doi.org/10.1371/journal.pbio.3001733.
Blagojevic-Stokic, Natasa, Paul Whiteley, Ben Marlow, and Jane Wills. 2026. “Autism as a Brain Energy Disorder: How Impairments in Brain Glucose Metabolism Give Rise to Autism Symptoms.” Brain Network Disorders, June. https://doi.org/10.1016/j.bnd.2026.04.002.
Choshen-Hillel, Shoham, Inbar Sadras, Tom Gordon-Hecker, Shir Genzer, David Rekhtman, Eugene M Caruso, Katherine L Clevers, et al. 2022. “Physicians Prescribe Fewer Analgesics During Night Shifts Than Day Shifts.” Proceedings of the National Academy of Sciences 119 (27): e2200047119. https://doi.org/10.1073/pnas.2200047119.
Constantinidis, Christos, Shintaro Funahashi, Daeyeol Lee, John D. Murray, Xue-Lian Qi, Min Wang, and Amy F. T. Arnsten. 2018. “Persistent Spiking Activity Underlies Working Memory.” Journal of Neuroscience 38 (32): 7020–28. https://doi.org/10.1523/JNEUROSCI.2486-17.2018.
Douaud, Gwenaëlle, Soojin Lee, Fidel Alfaro-Almagro, Christoph Arthofer, Chaoyue Wang, Paul McCarthy, Frederik Lange, et al. 2022. SARS-CoV-2 Is Associated with Changes in Brain Structure in UK Biobank.” Nature 604 (7907): 697–707. https://doi.org/10.1038/s41586-022-04569-5.
Dudai, Yadin, Avi Karni, and Jan Born. 2015. “The Consolidation and Transformation of Memory.” Neuron 88 (1): 20–32. https://doi.org/10.1016/j.neuron.2015.09.004.
Easterbrook, James A. 1959. “The Effect of Emotion on Cue Utilization and the Organization of Behavior.” Psychological Review 66 (3): 183–201. https://doi.org/10.1037/h0047707.
Gailliot, Matthew T, Roy F Baumeister, C Nathan DeWall, Jon K Maner, E Ashby Plant, Dianne M Tice, Lauren E Brewer, and Brandon J Schmeichel. 2007. “Self-Control Relies on Glucose as a Limited Energy Source: Willpower Is More Than a Metaphor.” Journal of Personality and Social Psychology 92 (2): 325–36. https://doi.org/10.1037/0022-3514.92.2.325.
Graveling, Alison J., Ian J. Deary, and Brian M. Frier. 2013. “Acute Hypoglycemia Impairs Executive Cognitive Function in Adults with and Without Type 1 Diabetes.” Diabetes Care 36 (10): 3240–46. https://doi.org/10.2337/dc13-0194.
Greenhouse-Tucknott, A., J. B. Butterworth, J. G. Wrightson, N. J. Smeeton, H. D. Critchley, J. Dekerle, and N. A. Harrison. 2022. “Toward the Unity of Pathological and Exertional Fatigue: A Predictive Processing Model.” Cognitive, Affective, & Behavioral Neuroscience 22 (2): 215–28. https://doi.org/10.3758/s13415-021-00958-x.
Guadagni, Veronica, Ford Burles, Michele Ferrara, and Giuseppe Iaria. 2014. “The Effects of Sleep Deprivation on Emotional Empathy.” Journal of Sleep Research 23 (6): 657–63. https://doi.org/10.1111/jsr.12192.
Hampshire, Adam, Adriana Azor, Christina Atchison, William Trender, Peter J Hellyer, Valentina Giunchiglia, Masud Husain, et al. 2024. “Cognition and Memory After Covid-19 in a Large Community Sample.” New England Journal of Medicine 390 (9): 806–18. https://doi.org/10.1056/NEJMoa2311330.
Ironside, Wallace. 1980. Conservation-Withdrawal and Action-Engagement: On a Theory of Survivor Behavior.” Psychosomatic Medicine 42 (1 Suppl): 163–75.
Jamadar, Sharna D., Anna Behler, Hamish Deery, and Michael Breakspear. 2025. “The Metabolic Costs of Cognition.” Trends in Cognitive Sciences 29 (6): 541–55. https://doi.org/10.1016/j.tics.2024.11.010.
Kandel, Eric R., Yadin Dudai, and Mark R. Mayford. 2014. The Molecular and Systems Biology of Memory. Cell. Vol. 157. 1. https://doi.org/10.1016/j.cell.2014.03.001.
Komaroff, Anthony L, and W Ian Lipkin. 2023. ME/CFS and Long COVID Share Similar Symptoms and Biological Abnormalities: Road Map to the Literature.” Frontiers in Medicine 10: 1187163. https://doi.org/10.3389/fmed.2023.1187163.
Kühn, Simone, Barbara C N Müller, Andries van der Leij, Ap Dijksterhuis, Marcel Brass, and Rick B van Baaren. 2011. “Neural Correlates of Emotional Synchrony.” Social Cognitive and Affective Neuroscience 6 (3): 368–74. https://doi.org/10.1093/scan/nsq044.
Lange, Gudrun, Jin-Mann S Lin, Yang Chen, et al. 2024. “Cognitive Assessment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Cognitive Substudy of the Multi-Site Clinical Assessment of ME/CFS (MCAM).” Frontiers in Neuroscience 18: 1460157. https://doi.org/10.3389/fnins.2024.1460157.
Magistretti, Pierre J., and Igor Allaman. 2018. “Lactate in the Brain: From Metabolic End-Product to Signalling Molecule.” Nature Reviews Neuroscience 19 (4): 235–49. https://doi.org/10.1038/nrn.2018.19.
Mashour, George A. 2024. “Anesthesia and the Neurobiology of Consciousness.” Neuron 112 (10): 1553–67. https://doi.org/10.1016/j.neuron.2024.03.002.
Miller, Andrew H., James F. Jones, Daniel F. Drake, Hao Tian, Elizabeth R. Unger, and Giuseppe Pagnoni. 2014. “Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue.” PLoS One 9 (5): e98156. https://doi.org/10.1371/journal.pone.0098156.
Morris, Gerwyn, George Anderson, Piotr Galecki, Michael Berk, and Michael Maes. 2013. “A Narrative Review on the Similarities and Dissimilarities Between Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Sickness Behavior.” BMC Medicine 11: 64. https://doi.org/10.1186/1741-7015-11-64.
Nakatomi, Yasuhito, Kei Mizuno, Akemi Ishii, Yasuhiro Wada, Masaaki Tanaka, Shusaku Tazawa, Kayo Onoe, et al. 2014. “Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.” Journal of Nuclear Medicine 55 (6): 945–50. https://doi.org/10.2967/jnumed.113.131045.
Novak, Peter, Maria Pilar Giannetti, Erica Weller, Mariana J. Hamilton, and Mariana Castells. 2022. “Mast Cell Disorders Are Associated with Decreased Cerebral Blood Flow and Small Fiber Neuropathy.” Annals of Allergy, Asthma & Immunology 128 (3): 299–306.e1. https://doi.org/10.1016/j.anai.2021.10.006.
Pellerin, Luc, and Pierre J. Magistretti. 1994. “Glutamate Uptake into Astrocytes Stimulates Aerobic Glycolysis: A Mechanism Coupling Neuronal Activity to Glucose Utilization.” Proceedings of the National Academy of Sciences 91 (22): 10625–29. https://doi.org/10.1073/pnas.91.22.10625.
Rimes, K. A., J. Ashcroft, L. Bryan, and T. Chalder. 2016. “Emotional Suppression in Chronic Fatigue Syndrome: Experimental Study.” Health Psychology 35 (9): 979–86. https://doi.org/10.1037/hea0000341.
Salamone, John D, and Merce Correa. 2012. “The Mysterious Motivational Functions of Mesolimbic Dopamine.” Neuron 76 (3): 470–85. https://doi.org/10.1016/j.neuron.2012.10.021.
Scholing, Janna M et al. 2025. “Greater Fatigue Is More Strongly Associated with Reduced Reward Sensitivity Than with Increased Effort Sensitivity: Evidence from a Post-COVID-19 Cohort.” Brain, Behavior, and Immunity - Health. https://doi.org/10.1016/j.bbih.2025.101001.
Siessmeier, Thomas, Waldemar A Nix, Jochen Hardt, Mathias Schreckenberger, Ulrich T Egle, and Peter Bartenstein. 2003. Observer Independent Analysis of Cerebral Glucose Metabolism in Patients with Chronic Fatigue Syndrome.” Journal of Neurology, Neurosurgery & Psychiatry 74 (7): 922–28.
Tamm, Sandra, Johanna Schwarz, Hanna Thuné, Göran Kecklund, Predrag Petrovic, Torbjörn Åkerstedt, Håkan Fischer, Mats Lekander, and Gustav Nilsonne. 2020. “A Combined fMRI and EMG Study of Emotional Contagion Following Partial Sleep Deprivation in Young and Older Humans.” Scientific Reports 10: 17944. https://doi.org/10.1038/s41598-020-74489-9.
Treadway, Michael T, Joshua W Buckholtz, Robin L Cowan, Neil D Woodward, Rui Li, M Salah Ansari, Ronald M Baldwin, Ariel N Schwartzman, Ronald M Kessler, and David H Zald. 2012. “Dopaminergic Mechanisms of Individual Differences in Human Effort-Based Decision-Making.” Journal of Neuroscience 32 (18): 6170–76. https://doi.org/10.1523/JNEUROSCI.6459-11.2012.
Vollmer-Conna, Ute, Cassandra Fazou, Barbara Cameron, Herong Li, Christine Brennan, Laurie Luck, Tracey Davenport, Denis Wakefield, Ian Hickie, and Andrew Lloyd. 2004. “Production of Pro-Inflammatory Cytokines Correlates with the Symptoms of Acute Sickness Behaviour in Humans.” Psychological Medicine 34 (7): 1289–97. https://doi.org/10.1017/s0033291704001953.
Walitt, Brian, Komudi Singh, Samuel R LaMunion, Mark Hallett, Sandra Jacobson, Kong Chen, Yoshihisa Enose-Akahata, et al. 2024. “Deep Phenotyping of Post-Infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Nature Communications 15 (1): 907. https://doi.org/10.1038/s41467-024-45107-3.
Wiehler, Antonius, Francesca Branzoli, Isaac Adanyeguh, Fanny Mochel, and Mathias Pessiglione. 2022. “A Neuro-Metabolic Account of Why Daylong Cognitive Work Alters the Control of Economic Decisions.” Current Biology 32 (16): 3564–75. https://doi.org/10.1016/j.cub.2022.06.074.
Williams, Grant E, Sharon Hausman-Cohen, Maryelaine Sotos, Emily Gutierrez, Carol Bilich, Francis W Mueller, and Shaun Jagshi. 2025. “The Role of GCH1 Deficiency and Tetrahydrobiopterin in Mental Health.” International Journal of Molecular Sciences 26 (16): 8030. https://doi.org/10.3390/ijms26168030.
Xu, H. et al. 2026. “Neurovascular and Synaptic Milieu of Brain-Resident Cells in Cognitive Dysfunction of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Journal of Translational Medicine 24 (1). https://doi.org/10.1186/s12967-026-08156-4.
Zhao, Sijia, Erin M Martin, Philipp A Reuken, Axel Scholcz, Andrea Ganse-Dumrath, Antje Srowig, Irina Utech, et al. 2024. “Long COVID Is Associated with Severe Cognitive Slowing: A Multicentre Cross-Sectional Study.” EClinicalMedicine 68: 102434. https://doi.org/10.1016/j.eclinm.2024.102434.
Zhu, Y., X. Li, H. Zhang, et al. 2025. “Metabolic Neuroimaging of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long-COVID.” Immunometabolism (Cobham) 7 (4): e00068. https://doi.org/10.1097/IN9.0000000000000068.